(MedPage Today) — The first therapy specifically indicated for chronic hand eczema (CHE) has passed muster at the FDA.
The agency approved delgocitinib cream 2% (Anzupgo) for adults with moderate-to-severe CHE, according to a statement from LEO…
Source link : https://www.medpagetoday.com/dermatology/atopy/116653
Author :
Publish date : 2025-07-24 14:45:00
Copyright for syndicated content belongs to the linked Source.
